Literature DB >> 3341993

Presence of a modified low density lipoprotein in humans.

P Avogaro1, G B Bon, G Cazzolato.   

Abstract

Low density lipoproteins (LDL) collected from 18 fasting humans were subjected to ion exchange chromatography on DEAE Sepharose. By this procedure, a LDL subfraction was isolated with an electric charge more negative than the LDL bulk. This LDL appeared to be mainly characterized by low phospholipid content, high free cholesterol and protein content, low esterified/free cholesterol ratio, and a high content of conjugated dienes, particularly of cholesterol esters. This subfraction, in an amount ranging from 5% to 20% of total LDL, was characterized by the presence of apo B-100 and protein aggregates that were reactive to anti-apo B monoclonal antibodies. Electron microscopy showed the more electronegative LDL to be heterogeneous in size with a tendency to aggregate. This LDL had low binding capacity with high affinity receptors of fibroblasts and low immunoreactivity with the monoclonal antibodies that recognize the receptor binding domain of apo B. Finally, the incubation of this LDL subfraction with cultured macrophages led to a higher increase in cellular cholesterol in spite of a lower rate of uptake as compared to the LDL bulk and to acetyl-LDL. The more electronegative LDL subfraction that we isolated for chemico-physical behavior and conjugated diene content may represent the peroxidized aliquot of human LDL.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3341993

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  59 in total

1.  When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid.

Authors:  M Bagnati; C Perugini; C Cau; R Bordone; E Albano; G Bellomo
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  Role of liver sinusoidal endothelial cells and stabilins in elimination of oxidized low-density lipoproteins.

Authors:  Ruomei Li; Ana Oteiza; Karen Kristine Sørensen; Peter McCourt; Randi Olsen; Bård Smedsrød; Dmitri Svistounov
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-28       Impact factor: 4.052

3.  Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis.

Authors:  J T Salonen; R Salonen; K Seppänen; M Kantola; S Suntioinen; H Korpela
Journal:  BMJ       Date:  1991-03-30

4.  Immunochemical analysis of the electronegative LDL subfraction shows that abnormal N-terminal apolipoprotein B conformation is involved in increased binding to proteoglycans.

Authors:  Cristina Bancells; Sònia Benítez; Jordi Ordóñez-Llanos; Katariina Öörni; Petri T Kovanen; Ross W Milne; José L Sánchez-Quesada
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

5.  Negatively charged low-density lipoprotein is associated with atherogenic risk in hypertensive patients.

Authors:  Jungo Urata; Satoshi Ikeda; Seiji Koga; Tomoo Nakata; Tomohiko Yasunaga; Koichiro Sonoda; Yuji Koide; Naoto Ashizawa; Shigeru Kohno; Koji Maemura
Journal:  Heart Vessels       Date:  2011-04-14       Impact factor: 2.037

Review 6.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

7.  Reducing oxidized lipids to prevent cardiovascular disease.

Authors:  Ngoc-Anh Le
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-08

8.  Circulating oxidized LDL, increased in patients with acute myocardial infarction, is accompanied by heavily modified HDL.

Authors:  Naoko Sawada; Takashi Obama; Shinji Koba; Takashi Takaki; Sanju Iwamoto; Toshihiro Aiuchi; Rina Kato; Masaki Kikuchi; Yuji Hamazaki; Hiroyuki Itabe
Journal:  J Lipid Res       Date:  2020-04-14       Impact factor: 5.922

9.  The expression of apolipoprotein B epitopes is normal in LDL of diabetic and end-stage renal disease patients.

Authors:  S Braschi; M Geoffrion; A Nguyen; Y Gaudreau; R W Milne
Journal:  Diabetologia       Date:  2006-04-04       Impact factor: 10.122

10.  Binding to heparin triggers deleterious structural and biochemical changes in human low-density lipoprotein, which are amplified in hyperglycemia.

Authors:  Shobini Jayaraman; Olivia R Chavez; Antonio Pérez; Inka Miñambres; Jose Luis Sánchez-Quesada; Olga Gursky
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-04-11       Impact factor: 4.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.